Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force

被引:3
|
作者
Fleurence, Rachael L. [1 ]
Kent, Seamus [2 ]
Adamson, Blythe [3 ]
Tcheng, James [4 ]
Balicer, Ran [5 ]
Ross, Joseph S. [6 ]
Haynes, Kevin [7 ]
Muller, Patrick [8 ]
Campbell, Jon [9 ]
Bouee-Benhamiche, Elsa [10 ]
Marti, Sebastian Garcia [1 ,11 ]
Ramsey, Scott [12 ]
机构
[1] Off Director, NIH, Bldg 1,9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Erasmus Univ, Erasmus Sch Hlth & Policy Management, Rotterdam, Netherlands
[3] Flatiron Hlth, New York, NY USA
[4] Duke Univ, Durham, NC USA
[5] Clalit Hlth Serv, Tel Aviv, Israel
[6] Yale Univ, Yale Sch Med, New Haven, CT USA
[7] Janssen Res & Dev, Titusville, NJ USA
[8] Natl Inst Hlth & Care Excellence, Ctr Guidelines, London, England
[9] Natl Pharmaceut Council, Washington, DC USA
[10] Inst Natl Canc, Publ Hlth & Healthcare Div, Boulogne Billancourt, France
[11] Inst Clin Effectiveness & Hlth Policy, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, Argentina
[12] Fred Hutchinson Canc Ctr, Hutchinson Inst Canc Outcomes Res, 100 Fairview Ave N, Seattle, WA 98109 USA
关键词
data quality; electronic health records; health technology assessment; real-world data; real-world evidence; QUALITY;
D O I
10.1016/j.jval.2024.01.019
中图分类号
F [经济];
学科分类号
02 ;
摘要
This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data can fill evidence gaps and improve decisions, several important limitations can affect its validity and relevance. The ISPOR framework includes 2 components: data delineation and data fitness for purpose. Data delineation provides a complete understanding of the data and an assessment of its trustworthiness by describing (1) data characteristics; (2) data provenance; and (3) data governance. Fitness for purpose comprises (1) data reliability items, ie, how accurate and complete the estimates are for answering the question at hand and (2) data relevance items, which assess how well the data are suited to answer the particular question from a decision making perspective. The report includes a checklist specific to EHR data reporting: the ISPOR SUITABILITY Checklist. It also provides recommendations for HTA agencies and policy makers to improve the use of EHR-derived data over time. The report concludes with a discussion of limitations and future directions in the field, including the potential impact from the substantial and rapid advances in the diffusion and capabilities of large language models and generative artificial intelligence. The report 's immediate audiences are HTA evidence developers and users. We anticipate that it will also be useful to other stakeholders, particularly regulators and manufacturers, in the future.
引用
收藏
页码:692 / 701
页数:10
相关论文
共 50 条
  • [21] HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
    Wang, Shirley, V
    Pottegard, Anton
    Crown, William
    Arlett, Peter
    Ashcroft, Darren M.
    Benchimol, Eric, I
    Berger, Marc L.
    Crane, Gracy
    Goettsch, Wim
    Hua, Wei
    Kabadi, Shaum
    Kern, David M.
    Kurz, Xavier
    Langan, Sinead
    Nonaka, Takahiro
    Orsini, Lucinda
    Perez-Gutthann, Susana
    Pinheiro, Simone
    Pratt, Nicole
    Schneeweiss, Sebastian
    Toussi, Massoud
    Williams, Rebecca J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (01) : 44 - 55
  • [22] HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force
    Wang, Shirley, V
    Pottegard, Anton
    Crown, William
    Arlett, Peter
    Ashcroft, Darren M.
    Benchimol, Eric, I
    Berger, Marc L.
    Crane, Gracy
    Goettsch, Wim
    Hua, Wei
    Kabadi, Shaum
    Kern, David M.
    Kurz, Xavier
    Langan, Sinead
    Nonaka, Takahiro
    Orsini, Lucinda
    Perez-Gutthann, Susana
    Pinheiro, Simone
    Pratt, Nicole
    Schneeweiss, Sebastian
    Toussi, Massoud
    Williams, Rebecca J.
    VALUE IN HEALTH, 2022, 25 (10) : 1663 - 1672
  • [23] From real-world electronic health record data to real-world results using artificial intelligence
    Knevel, Rachel
    Liao, Katherine P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03) : 306 - 311
  • [24] Multiple Criteria Decision Analysis for Health Care Decision Making-Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
    Marsh, Kevin
    IJzerman, Maarten
    Thokala, Praveen
    Baltussen, Rob
    Boysen, Meindert
    Kalo, Zoltan
    Lonngren, Thomas
    Mussen, Filip
    Peacock, Stuart
    Watkins, John
    Devlin, Nancy
    VALUE IN HEALTH, 2016, 19 (02) : 125 - 137
  • [25] A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force
    Bridges, John F. P.
    de Bekker-Grob, Esther W.
    Hauber, Brett
    Heidenreich, Sebastian
    Janssen, Ellen
    Bast, Alice
    Hanmer, Janel
    Danyliv, Andriy
    Low, Eric
    Bouvy, Jacoline C.
    Marshall, Deborah A.
    VALUE IN HEALTH, 2023, 26 (02) : 153 - 162
  • [26] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES
    Harwood, M.
    Deighton, A.
    Mickle, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2019, 22 : S863 - S863
  • [27] The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment
    Cox, Oliver
    Sammon, Cormac
    Simpson, Alex
    Wasiak, Radek
    Ramagopalan, Sreeram
    Thorlund, Kristian
    VALUE IN HEALTH, 2022, 25 (07) : 1253 - 1256
  • [28] REAL-WORLD DATA TO SUPPORT SURROGATE ENDPOINT EVALUATION FOR HEALTH TECHNOLOGY ASSESSMENT
    Dupin, J.
    Thokagevistk, K.
    Emonnot, L.
    Micon, S.
    Benyounes, K.
    Haves, D.
    Civet, A.
    Pau, D.
    Le Dissez, C.
    Gally, S.
    Esnault, C.
    VALUE IN HEALTH, 2022, 25 (12) : S456 - S457
  • [29] The use of real-world data in health technology assessment of medications for rare diseases
    Qian, Christina J.
    Mickle, Alexis T.
    Deighton, Alison M.
    Harwood, Meagan M.
    Szabo, Shelagh M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 259 - 259
  • [30] The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies
    Karen, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 218 - 218